Production (Stage)
Tandem Diabetes Care, Inc.
TNDM
$20.72
$0.080.39%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.30% | 43.62% | 31.43% | 13.27% | 13.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.30% | 43.62% | 31.43% | 13.27% | 13.16% |
| Cost of Revenue | 19.60% | 20.96% | 24.46% | 15.86% | 12.17% |
| Gross Profit | 25.07% | 68.77% | 38.88% | 10.87% | 14.19% |
| SG&A Expenses | 16.49% | 20.47% | 25.60% | 12.85% | 0.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.24% | 21.06% | 24.36% | 14.53% | 6.82% |
| Operating Income | 17.24% | 98.43% | 17.28% | -24.55% | 15.06% |
| Income Before Tax | -208.86% | 100.05% | 26.41% | 14.11% | 68.01% |
| Income Tax Expenses | 165.76% | 43.50% | -71.46% | -6.54% | 1,010.10% |
| Earnings from Continuing Operations | -205.64% | 102.52% | 29.46% | 13.87% | 65.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -205.64% | 102.52% | 29.46% | 13.87% | 65.52% |
| EBIT | 17.24% | 98.43% | 17.28% | -24.55% | 15.06% |
| EBITDA | 19.80% | 111.06% | 20.49% | -30.43% | 17.60% |
| EPS Basic | -200.67% | 102.48% | 29.91% | 14.08% | 65.93% |
| Normalized Basic EPS | 8.19% | 105.98% | 26.86% | -34.82% | 15.66% |
| EPS Diluted | -200.67% | 102.48% | 29.91% | 14.08% | 65.93% |
| Normalized Diluted EPS | 8.19% | 105.95% | 26.86% | -34.82% | 15.66% |
| Average Basic Shares Outstanding | 1.65% | 0.87% | 0.65% | 0.25% | 1.20% |
| Average Diluted Shares Outstanding | 1.65% | 1.21% | 0.65% | 0.25% | 1.20% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |